Sanofi-Aventis U.S. LLC et al v. Actavis LLC et al
Sanofi Mature IP and Sanofi-Aventis U.S. LLC |
Hetero Labs Ltd., Belcher Pharmaceuticals, LLC, Glenmark Pharmaceuticals Ltd., Glenmark Pharmaceuticals Inc., USA, Actavis LLC, Apotex Inc., Hetero Labs Ltd. Unit-VI, Dr. Reddy's Laboratories, Ltd., Actavis Elizabeth LLC, BPI Labs, LLC, Fresenius Kabi USA, LLC, Dr. Reddy's Laboratories, Inc., Sandoz Inc., Breckenridge Pharmaceutical, Inc., Apotex Corp., Hetero USA, Inc., MSN Pharmaceuticals, Inc., Accord Healthcare Inc., Mylan Laboratories Limited and MSN Laboratories Private Ltd. |
1:2020cv00804 |
June 12, 2020 |
US District Court for the District of Delaware |
Richard G Andrews |
Patent - Abbreviated New Drug Application(ANDA) |
35 U.S.C. § 271 |
None |
Docket Report
This docket was last retrieved on June 26, 2023. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 77 NOTICE OF SERVICE of Plaintiffs' Rule 26(a)(1) Initial Disclosures filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC.(Blumenfeld, Jack) |
Filing 76 NOTICE OF SERVICE of Fresenius Kabi USA, LLCs Initial Disclosures pursuant to Fed. R. Civ. P. 26(a) filed by Fresenius Kabi USA, LLC.(Gattuso, Dominick) |
Filing 75 NOTICE OF SERVICE of Sandoz Inc.s Initial Disclosures pursuant to Fed. R. Civ. P. 26(a) filed by Sandoz Inc..(Gattuso, Dominick) |
Filing 74 NOTICE OF SERVICE of Rule 26(a) Initial Disclosures filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Ormerod, Eve) |
Filing 73 NOTICE OF SERVICE of Mylan Laboratories Limited's Rule 26(a)(1) Initial Disclosures filed by Mylan Laboratories Limited.(Palapura, Bindu) |
Filing 72 NOTICE OF SERVICE of Defendants Apotex Inc.'s and Apotex Corp.'s Rule 26(a)(1) Initial Disclosures filed by Apotex Corp., Apotex Inc..(Haney, Megan) |
Filing 71 NOTICE OF SERVICE of Actavis LLCs Initial Disclosures filed by Actavis LLC.(Keller, Karen) |
Filing 70 NOTICE OF SERVICE of Breckenridge Pharmaceutical, Inc.s Rule 26(a)(1) Initial Disclosures filed by Breckenridge Pharmaceutical, Inc..(Farnan, Kelly) |
Filing 69 ANSWER to #62 Amended Complaint, and COUNTERCLAIMS against Sanofi Mature IP, Sanofi-Aventis U.S. LLC, by Breckenridge Pharmaceutical, Inc..(Farnan, Kelly) Modified on 8/7/2020 (nms). |
Filing 68 ANSWER to First Amended Complaint (see 20-761-RGA), Separate Defenses, and COUNTERCLAIMS against Sanofi Mature IP, Sanofi-Aventis U.S. LLC, by Mylan Laboratories Limited.(Palapura, Bindu) Modified on 8/5/2020 (nms). |
Filing 67 ORAL ORDER: The Rule 16(b) Conference set for 8/7/2020, is CANCELED. Ordered by Judge Richard G. Andrews on 8/5/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms) |
Filing 66 SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Case referred to a Magistrate Judge to handle all discovery disputes including any that arise in connection with expert reports. These actions are consolidated for all purposes and all papers shall be filed in Civil Action No. 20-804-RGA. Joinder of Parties due by 12/11/2020. Amended Pleadings due by 12/11/2020. Discovery due by 12/18/2020. Joint Claim Construction Brief due by 11/25/2020. A Markman Hearing is set for 12/17/2020, at 9:00 AM in Courtroom 6A. A Pretrial Conference is set for 5/14/2021, at 9:00 AM in Courtroom 6A. A 3 day ench Trial is set to start 5/24/2021, at 8:30 AM in Courtroom 6A (see Order for further details). Signed by Judge Richard G. Andrews on 8/5/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms) Modified on 8/5/2020 (nms). |
Filing 65 PROPOSED Scheduling Order, by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Attachments: #1 Letter)(Blumenfeld, Jack) Modified on 8/5/2020 (nms). |
CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at # https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf Associated Cases: 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(cak) |
Pro Hac Vice Attorney Tiffany Mahmood for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 64 Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding dial-in information for the August 7, 2020 scheduling teleconference. (Blumenfeld, Jack) |
Pro Hac Vice Attorneys Andrew M. Alul and Roshan P. Shrestha for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 63 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,716,777 . (Blumenfeld, Jack) |
Filing 62 First AMENDED COMPLAINT against Actavis LLC, Apotex Corp., Apotex Inc., Breckenridge Pharmaceutical, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Fresenius Kabi USA, LLC, Sandoz Inc.- filed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. (Attachments: #1 Exhibits A-C)(Blumenfeld, Jack) |
Pro Hac Vice Attorneys William E. Solander and Daniel J. Minion for Sanofi Mature IP and Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(kmd) |
Pro Hac Vice Attorney Daryl L. Wiesen for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 61 SO ORDERED Granting #60 Proposed Dismissal Order as to BPI (*Party BPI Labs, LLC and Belcher Pharmaceuticals, LLC terminated). Signed by Judge Richard G. Andrews on 7/30/2020. (nms) |
Filing 60 PROPOSED Dismissal Order as to BPI, by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Blumenfeld, Jack) Modified on 7/30/2020 (nms). |
Filing 59 SO ORDERED Granting #58 Proposed Dismissal Order as to Hetero (*Party Hetero USA, Inc., Hetero Labs Ltd. and Hetero Labs Ltd. Unit-VI terminated). Signed by Judge Richard G. Andrews on 7/30/2020. (nms) |
Filing 58 PROPOSED Dismissal Order as to Hetero, by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Blumenfeld, Jack) Modified on 7/30/2020 (nms). |
Pro Hac Vice Attorney Aviv A. Zalcenstein for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Pro Hac Vice Attorneys Frank D. Rodriguez and James P. Barabas for Dr. Reddy's Laboratories, Inc. and Dr. Reddy's Laboratories, Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Pro Hac Vice Attorney Joel L. Broussard for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
Pro Hac Vice Attorney Emily L. Rapalino for Sandoz Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
Filing 57 MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, Emily L. Rapalino Tiffany Mahmood, Aviv A. Zalcenstein and Joel L. Broussard - filed by Sandoz Inc.. (Gattuso, Dominick) |
Filing 56 MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez and James P. Barabas - filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Ormerod, Eve) |
SO ORDERED, re #57 MOTION for Pro Hac Vice Appearance of Attorney Daryl L. Wiesen, Emily L. Rapalino Tiffany Mahmood, Aviv A. Zalcenstein and Joel L. Broussard, filed by Sandoz Inc.. Signed by Judge Richard G. Andrews on 7/23/2020. (nms) |
SO ORDERED, re #56 MOTION for Pro Hac Vice Appearance of Attorney Frank D. Rodriguez and James P. Barabas, filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. Signed by Judge Richard G. Andrews on 7/23/2020. (nms) |
Pro Hac Vice Attorney Derek B. Lavender for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mal) |
Filing 55 MOTION for Pro Hac Vice Appearance of Attorney Derek B. Lavender - filed by Apotex Corp., Apotex Inc.. (Attachments: #1 Certification of Derek B. Lavender)(Haney, Megan) |
Filing 54 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul and Roshan P. Shrestha, Ph.D. - filed by Apotex Corp., Apotex Inc.. (Attachments: #1 Certification of Andrew M. Alul, #2 Certification of Roshan P. Shrestha, Ph.D.)(Haney, Megan) |
Filing 53 SO ORDERED Granting #38 Stipulation and Order (*Party Actavis Elizabeth LLC terminated). Signed by Judge Richard G. Andrews on 7/21/2020. (nms) |
SO ORDERED, re #42 Unopposed MOTION for Extension of Time to Respond to the Complain (*Reset Answer Deadlines: BPI Labs, LLC answer due 8/3/2020; Belcher Pharmaceuticals, LLC answer due 8/3/2020). Signed by Judge Richard G. Andrews on 7/21/2020. (nms) |
SO ORDERED, re #54 MOTION for Pro Hac Vice Appearance of Attorney Andrew M. Alul and Roshan P. Shrestha, Ph.D., filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 7/21/2020. (nms) |
SO ORDERED, re #55 MOTION for Pro Hac Vice Appearance of Attorney Derek B. Lavender, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 7/21/2020. (nms) |
Filing 52 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Fresenius Kabi Pharmaceuticals Holding, LLC, Other Affiliate Fresenius Kabi AG for Fresenius Kabi USA, LLC filed by Fresenius Kabi USA, LLC. (Gattuso, Dominick) |
Filing 51 ANSWER to #1 Complaint and COUNTERCLAIMS against All Plaintiffs, by Fresenius Kabi USA, LLC.(Gattuso, Dominick) Modified on 7/21/2020 (nms). |
Filing 50 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Novartis AG for Sandoz Inc. filed by Sandoz Inc.. (Gattuso, Dominick) |
Filing 49 ANSWER to #1 Complaint, Defenses, and Counterclaims against All Plaintiffs, by Sandoz Inc..(Gattuso, Dominick) Modified on 7/21/2020 (nms). |
Filing 48 NOTICE of Appearance by Megan C. Haney on behalf of Apotex Corp., Apotex Inc. (Haney, Megan) |
Filing 47 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Aposherm Delaware Holdings Corporation for Apotex Corp.; Corporate Parent Apotex Pharmaceuticals Holdings Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Phillips, John) |
Filing 46 ANSWER to #1 Complaint, Affirmative Defenses, and COUNTERCLAIMS against All Plaintiffs, by Apotex Corp., Apotex Inc..(Phillips, John) Modified on 7/21/2020 (nms). |
Filing 45 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Towa Pharma International Holdings S.L for Breckenridge Pharmaceutical, Inc. filed by Breckenridge Pharmaceutical, Inc.. (Farnan, Kelly) |
Filing 44 ANSWER to #1 Complaint and COUNTERCLAIMS against Sanofi Mature IP, Sanofi-Aventis U.S. LLC, by Breckenridge Pharmaceutical, Inc..(Farnan, Kelly) Modified on 7/20/2020 (nms). |
Filing 43 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Dr. Reddy's Laboratories, Ltd., Corporate Parent Dr. Reddy's Laboratories SA for Dr. Reddy's Laboratories, Inc. filed by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd.. (Ormerod, Eve) |
Filing 42 Unopposed MOTION for Extension of Time to Respond to the Complaint - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Blumenfeld, Jack) Modified on 7/21/2020 (nms). |
Filing 41 Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate Teva Pharmaceutical Industries Ltd., Other Affiliate Teva Pharmaceuticals, USA, Inc. for Actavis LLC filed by Actavis LLC. (Keller, Karen) |
Filing 40 ANSWER to #1 Complaint and COUNTERCLAIMS against Sanofi Mature IP, Sanofi-Aventis U.S. LLC, by Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd..(Ormerod, Eve) Modified on 7/20/2020 (nms). |
Filing 39 ANSWER to #1 Complaint and COUNTERCLAIMS against Sanofi Mature IP, Sanofi-Aventis U.S. LLC, by Actavis LLC.(Keller, Karen) Modified on 7/21/2020 (nms). |
Filing 38 STIPULATION and Proposed Order, by Actavis Elizabeth LLC, Actavis LLC. (Keller, Karen) Modified on 7/20/2020 (nms). |
Filing 37 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hetero Drugs Limited, Corporate Parent Hetero Labs Limited for Hetero USA, Inc. filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit-VI, Hetero USA, Inc.. (Dorsney, Kenneth) |
Filing 36 ANSWER to #1 Complaint,, by Hetero Labs Ltd., Hetero Labs Ltd. Unit-VI, Hetero USA, Inc..(Dorsney, Kenneth) |
CORRECTING ENTRY: The disclosure statement filed at D.I. 45 has been removed from the docket per counsel's request. The correct disclosure statement will be refiled. (nms) |
Pro Hac Vice Attorneys Sarita M. Matheson and Todd S. Werner for Hetero Labs Ltd., Hetero Labs Ltd. Unit-VI, Hetero USA, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 35 SO ORDERED, re #34 MOTION for Pro Hac Vice Appearance of Attorney Sarita M. Matheson and Attorney Todd S. Werner, filed by Hetero Labs Ltd. Unit-VI, Hetero USA, Inc., Hetero Labs Ltd.. Signed by Judge Richard G. Andrews on 7/8/2020. (nms) |
Filing 34 MOTION for Pro Hac Vice Appearance of Attorney Sarita M. Matheson and Attorney Todd S. Werner - filed by Hetero Labs Ltd., Hetero Labs Ltd. Unit-VI, Hetero USA, Inc.. (Dorsney, Kenneth) |
Pro Hac Vice Attorneys C. Kyle Musgrove, Elizabeth M. Crompton, John W. Bateman for Breckenridge Pharmaceutical, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
Filing 33 Order Setting Rule 16(b) Telephone Conference: A Scheduling Conference is set for 8/7/2020, at 10:00 AM in Chambers before Judge Richard G. Andrews (see Order for further details). Signed by Judge Richard G. Andrews on 7/6/2020. (nms) |
Filing 32 MOTION for Pro Hac Vice Appearance of Attorney C. Kyle Musgrove, Elizabeth M. Crompton and John W. Bateman - filed by Breckenridge Pharmaceutical, Inc.. (Farnan, Kelly) |
SO ORDERED, re #32 MOTION for Pro Hac Vice Appearance of Attorney C. Kyle Musgrove, Elizabeth M. Crompton and John W. Bateman, filed by Breckenridge Pharmaceutical, Inc.. Signed by Judge Richard G. Andrews on 7/6/2020. (nms) |
SO ORDERED, re #31 STIPULATION TO EXTEND TIME to answer the Complaint to July 20, 2020 (*Reset Answer Deadlines: Breckenridge Pharmaceutical, Inc. answer due 7/20/2020). Signed by Judge Richard G. Andrews on 7/6/2020. (nms) |
Filing 31 STIPULATION TO EXTEND TIME to answer the Complaint to July 20, 2020 - filed by Breckenridge Pharmaceutical, Inc.. (Farnan, Kelly) |
Filing 30 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to July 20, 2020 - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) Modified on 6/30/2020 (nms). |
Pro Hac Vice Attorney Michael S. Scerbo for Sanofi Mature IP and Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(mal) |
SO ORDERED, re #30 STIPULATION TO EXTEND TIME to Answer, Move, or Otherwise Respond to the Complaint to July 20, 2020 (*Reset Answer Deadlines: Dr. Reddy's Laboratories, Inc. answer due 7/20/2020; Dr. Reddy's Laboratories, Ltd. answer due 7/20/2020). Signed by Judge Richard G. Andrews on 6/30/2020. (nms) |
Filing 29 Letter to The Honorable Richard G. Andrews from Jack B. Blumenfeld regarding request for an early Rule 16 conference. (Blumenfeld, Jack) |
Filing 28 STIPULATION TO EXTEND TIME to answer, move, or otherwise respond to the complaint to July 20, 2020 - filed by Actavis Elizabeth LLC, Actavis LLC. (Shaw, John) |
Filing 27 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to July 20, 2020 - filed by Fresenius Kabi USA, LLC, Sandoz Inc.. (Gattuso, Dominick) |
Filing 26 NOTICE of Appearance by Dominick T. Gattuso on behalf of Fresenius Kabi USA, LLC, Sandoz Inc. (Gattuso, Dominick) |
Filing 25 Unopposed Motion to Extend Time - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Blumenfeld, Jack) Modified on 6/26/2020 (nms). |
SO ORDERED, re #28 STIPULATION and Order to Extend Time (*Reset Answer Deadlines: Actavis Elizabeth LLC answer due 7/20/2020; Actavis LLC answer due 7/20/2020). Signed by Judge Richard G. Andrews on 6/26/2020. (nms) |
SO ORDERED, re #27 STIPULATION TO EXTEND TIME to answer, move or otherwise respond to the Complaint to July 20, 2020 (*Reset Answer Deadlines: Fresenius Kabi USA, LLC answer due 7/20/2020; Sandoz Inc. answer due 7/20/2020). Signed by Judge Richard G. Andrews on 6/26/2020. (nms) |
SO ORDERED, re #25 Unopposed Motion to Extend Time (*Reset Answer Deadlines: BPI Labs, LLC answer due 7/20/2020; Belcher Pharmaceuticals, LLC answer due 7/20/2020). Signed by Judge Richard G. Andrews on 6/26/2020. (nms) |
Pro Hac Vice Attorney Whitney L. Meier for Sanofi Mature IP,for Sanofi-Aventis U.S. LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
SO ORDERED, re (10 in 20-cv-761-RGA; 11 in 20-cv-46-RGA; 9 in 20-cv-803-RGA; 24 in 20-cv-804-RGA) MOTION for Pro Hac Vice Appearance of Attorney Jiang Lin, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 6/25/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms) |
Filing 24 MOTION for Pro Hac Vice Appearance of Attorney Jiang Lin - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
Filing 23 MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Daniel J. Minion, Whitney L. Meier and Michael S. Scerbo - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
SO ORDERED, re (9 in 20-cv-761-RGA; 8 in 20-cv-803-RGA; 10 in 20-cv-646-RGA; 23 in 20-cv-804-RGA) MOTION for Pro Hac Vice Appearance of Attorney William E. Solander, Daniel J. Minion, Whitney L. Meier and Michael S. Scerbo, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. Signed by Judge Richard G. Andrews on 6/24/2020. Associated Cases: 1:20-cv-00646-RGA, 1:20-cv-00761-RGA, 1:20-cv-00803-RGA, 1:20-cv-00804-RGA(nms) |
Filing 22 SO ORDERED Granting #20 Stipulation and Order of Dismissal as to Glenmark (*Party Glenmark Pharmaceuticals Inc., USA and Glenmark Pharmaceuticals Ltd. terminated). Signed by Judge Richard G. Andrews on 6/22/2020. (nms) |
SO ORDERED, re #21 Unopposed MOTION to Extend Time (*Reset Answer Deadlines: Hetero Labs Ltd. answer due 7/20/2020; Hetero Labs Ltd. Unit-VI answer due 7/20/2020; Hetero USA, Inc. answer due 7/20/2020). Signed by Judge Richard G. Andrews on 6/22/2020. (nms) |
Filing 21 Unopposed MOTION to Extend Time - filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Blumenfeld, Jack) Modified on 6/19/2020 (nms). |
Filing 20 STIPULATION and [Proposed] Order of Dismissal as to Glenmark, by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Blumenfeld, Jack) Modified on 6/19/2020 (nms). |
Filing 19 STIPULATION TO EXTEND TIME for Apotex to answer, move or otherwise respond to Complaint to July 20, 2020 - filed by Apotex Corp., Apotex Inc.. (Phillips, John) Modified on 6/19/2020 (nms). |
Filing 18 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. Apotex Inc. served on 6/19/2020, answer due 7/10/2020. (Fahnestock, Derek) |
SO ORDERED, re #19 STIPULATION TO EXTEND TIME for Apotex to answer, move or otherwise respond to the Complaint to July 20, 2020 (*Reset Answer Deadlines: Apotex Corp. answer due 7/20/2020; Apotex Inc. answer due 7/20/2020). Signed by Judge Richard G. Andrews on 6/19/2020. (nms) |
Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:20-cv-00803-RGA, 1:20-cv-00804-RGA (rjb) |
Filing 17 AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Sandoz Inc. on June 16, 2020, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
Filing 16 AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Belcher Pharmaceuticals, LLC on June 16, 2020, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
Filing 15 AFFIDAVIT of Service for Summons, Complaint and Related Papers served on Dr. Reddy's Laboratories Inc. on June 16, 2020, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
Filing 14 AFFIDAVIT of Service for Summons, Complaint and Related Papers served on BPI Labs, LLC on June 16, 2020, filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (Fahnestock, Derek) |
Filing 13 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. Hetero USA, Inc. served on 6/15/2020, answer due 7/6/2020. (Blumenfeld, Jack) |
Filing 12 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. Glenmark Pharmaceuticals Inc., USA served on 6/15/2020, answer due 7/6/2020. (Blumenfeld, Jack) |
Filing 11 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. Fresenius Kabi USA, LLC served on 6/15/2020, answer due 7/6/2020. (Blumenfeld, Jack) |
Filing 10 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. Breckenridge Pharmaceutical, Inc. served on 6/15/2020, answer due 7/6/2020. (Blumenfeld, Jack) |
Filing 9 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. Apotex Corp. served on 6/15/2020, answer due 7/6/2020. (Blumenfeld, Jack) |
Filing 8 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. Actavis LLC served on 6/15/2020, answer due 7/6/2020. (Blumenfeld, Jack) |
Filing 7 SUMMONS Returned Executed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. Actavis Elizabeth LLC served on 6/15/2020, answer due 7/6/2020. (Blumenfeld, Jack) |
Filing 6 Summonses Issued (please complete the top portion of the form and print out for use/service). (myr) |
Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sanofi for Sanofi Mature IP, Sanofi-Aventis U.S. LLC filed by Sanofi Mature IP, Sanofi-Aventis U.S. LLC. (myr) |
Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,583,110 B2. (myr) |
Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not Applicable. Date of Expiration of Patent: October 27, 2030. Thirty Month Stay Deadline:Not Applicable (myr) |
Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (myr) |
Filing 1 COMPLAINT FOR PATENT INFRINGEMENT filed against Actavis Elizabeth LLC, Actavis LLC, Apotex Corp., Apotex Inc., BPI Labs, LLC, Belcher Pharmaceuticals, LLC, Breckenridge Pharmaceutical, Inc., Dr. Reddy's Laboratories, Inc., Dr. Reddy's Laboratories, Ltd., Fresenius Kabi USA, LLC, Glenmark Pharmaceuticals Inc., USA, Glenmark Pharmaceuticals Ltd., Hetero Labs Ltd., Hetero Labs Ltd. Unit-VI, Hetero USA, Inc., Sandoz Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-2991969.) - filed by Sanofi-Aventis U.S. LLC, Sanofi Mature IP. (Attachments: #1 Exhibit A-B, #2 Civil Cover Sheet)(myr) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.